<?xml version="1.0" ?>
<GlossaryTerm id="CDR0000346487">
  <TermName>anakinra</TermName>
  <TermPronunciation>(A-nuh-KIN-ruh)</TermPronunciation>
  <TermDefinition>
    <DefinitionText>A substance that is used to treat rheumatoid arthritis, and is being studied in the treatment of cancer. Anakinra blocks the action of interleukin 1 (IL-1). It is a type of interleukin receptor antagonist. Also called Kinaret.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </TermDefinition>
  <MediaLink ref="CDR0000711564" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;anakinra&quot;" language="en" id="_3"/>
  <MediaLink ref="CDR0000711563" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;anakinra&quot;" language="es" id="_4"/>
  <SpanishTermName>anakinra</SpanishTermName>
  <SpanishTermDefinition>
    <DefinitionText>Sustancia que se usa para tratar la artritis reumatoide y que está en estudio para el tratamiento de cáncer. La anakinra bloquea la acción de la interleucina 1 (IL-1). Es un tipo de antagonista del receptor de interleucina. También se llama Kinaret.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </SpanishTermDefinition>
  <DateFirstPublished>2003-11-20</DateFirstPublished>
  <DateLastModified>2007-01-18</DateLastModified>
</GlossaryTerm>
